Alternatively, it reportedly also promotes the expression of CD38 in APL cells.17, 18, 19, 20 Here, we showed that ATRA may be useful for immunotherapy with T cells harboring anti-CD38-CAR through the enhancement of CD38 expression for patients with AML. This evidence concerns the gene CD38 and acute promyelocytic leukemia.